These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 37302518)
1. HHEX suppresses advanced thyroid cancer by interacting with TLE3. Xu Z; Feng Y; Yan Y; Jin H; Chen Y; Han Y; Huang S; Feng F; Fu H; Yin Y; Huang Y; Wang H; Cheng W Mol Cell Endocrinol; 2023 Aug; 574():111988. PubMed ID: 37302518 [TBL] [Abstract][Full Text] [Related]
2. RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3. Liu L; Zhang Y; Wong CC; Zhang J; Dong Y; Li X; Kang W; Chan FKL; Sung JJY; Yu J Cancer Res; 2018 Apr; 78(8):1958-1971. PubMed ID: 29374067 [TBL] [Abstract][Full Text] [Related]
3. The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development. Laidlaw BJ; Duan L; Xu Y; Vazquez SE; Cyster JG Nat Immunol; 2020 Sep; 21(9):1082-1093. PubMed ID: 32601467 [TBL] [Abstract][Full Text] [Related]
4. Transmembrane protein 88 exerts a tumor-inhibitory role in thyroid cancer through restriction of Wnt/β-catenin signaling. Geng Q; Chen X; Chen N Exp Cell Res; 2020 Oct; 395(2):112193. PubMed ID: 32710906 [TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells. Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573 [TBL] [Abstract][Full Text] [Related]
6. CENPA knockdown restrains cell progression and tumor growth in breast cancer by reducing PLA2R1 promoter methylation and modulating PLA2R1/HHEX axis. Wu G; Fan Z; Li X Cell Mol Life Sci; 2024 Jan; 81(1):27. PubMed ID: 38212546 [TBL] [Abstract][Full Text] [Related]
7. Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells. Li X; Ma G; Guo W; Mu N; Wang Y; Liu X; Su L Cell Commun Signal; 2021 Jul; 19(1):80. PubMed ID: 34321041 [TBL] [Abstract][Full Text] [Related]
8. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway. Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770 [TBL] [Abstract][Full Text] [Related]
9. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling. Geng Q; Deng H; Fu J; Cui F Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034 [TBL] [Abstract][Full Text] [Related]
10. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells. Qiu W; Yang Z; Fan Y; Zheng Q Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298 [TBL] [Abstract][Full Text] [Related]
11. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling. Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359 [TBL] [Abstract][Full Text] [Related]
12. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway. Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390 [TBL] [Abstract][Full Text] [Related]
13. Expression of TLE3 by bone marrow stromal cells is regulated by canonical Wnt signaling. Kokabu S; Sato T; Ohte S; Enoki Y; Okubo M; Hayashi N; Nojima J; Tsukamoto S; Fukushima Y; Sakata Y; Katagiri T; Rosen V; Yoda T FEBS Lett; 2014 Feb; 588(4):614-9. PubMed ID: 24444608 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway. Zhou Z; Liu Y; Ma M; Chang L Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013 [TBL] [Abstract][Full Text] [Related]
15. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer. Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429 [TBL] [Abstract][Full Text] [Related]
16. A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Kitchen P; Lee KY; Clark D; Lau N; Lertsuwan J; Sawasdichai A; Satayavivad J; Oltean S; Afford S; Gaston K; Jayaraman PS Cancer Res; 2020 Feb; 80(4):757-770. PubMed ID: 31843982 [TBL] [Abstract][Full Text] [Related]
17. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway. Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335 [TBL] [Abstract][Full Text] [Related]
18. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway. Wu Y; Chen W; Zhang B; Liu H Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180 [TBL] [Abstract][Full Text] [Related]
20. [Nuclear translocation of β-catenin represses membrane localization of NIS in human thyroid cancer cells]. Lan L; Deng W; Chen H; Huo L; Deng L; Zhang G; Luo Y Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):891-6. PubMed ID: 27045654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]